Stoke Therapeutics (STOK) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to -$439.8 million.
- Stoke Therapeutics' Retained Earnings rose 844.53% to -$439.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$439.8 million, marking a year-over-year increase of 844.53%. This contributed to the annual value of -$490.8 million for FY2024, which is 2214.29% down from last year.
- Per Stoke Therapeutics' latest filing, its Retained Earnings stood at -$439.8 million for Q3 2025, which was up 844.53% from -$401.4 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Retained Earnings ranged from a high of -$220.7 million in Q1 2022 and a low of -$490.8 million during Q4 2024
- Its 4-year average for Retained Earnings is -$370.3 million, with a median of -$378.0 million in 2025.
- As far as peak fluctuations go, Stoke Therapeutics' Retained Earnings plummeted by 4483.4% in 2023, and later skyrocketed by 1173.97% in 2025.
- Stoke Therapeutics' Retained Earnings (Quarter) stood at -$297.2 million in 2022, then plummeted by 35.23% to -$401.8 million in 2023, then fell by 22.14% to -$490.8 million in 2024, then grew by 10.4% to -$439.8 million in 2025.
- Its Retained Earnings stands at -$439.8 million for Q3 2025, versus -$401.4 million for Q2 2025 and -$378.0 million for Q1 2025.